Ltd.

XX Targi GL EVENTS RUIHE (SHANGHAI) EXHIBITION CO., LTD. i III Targi CISCE w Nanchang z rekordową liczbą uczestników

by

NANCHANG, Chiny, 12 czerwca 2023 /PRNewswire/ — W dniach 28-30 maja 2023 roku w Nanchang w Chinach z powodzeniem odbyły się XX Targi CACLP (Chińskiego Stowarzyszenia Laboratoriów Klinicznych) oraz III Targi CISCE (Chińskiego Łańcucha Dostaw na potrzeby diagnostyki in vitro), uznawane za wiodące na świecie targi diagnostyki in vitro (IVD). PR1 W wydarzeniu wzięło udział … Read more

Рекордное количество участников на 20-й выставке CACLP и 3-й выставке CISCE в Нанчане

by

НАНЧАН, Китай, 12 июня 2023 г. /PRNewswire/ — С 28 по 30 мая 2023 г. в Нанчане, Китай, прошла 20-я выставка Китайской ассоциации клинической лабораторной практики (CACLP) и 3-я Китайская выставка IVD Supply Chain Expo (CISCE), признанные ведущими выставка диагностики in vitro (IVD) в мире. PR1 На выставочной площади в 130 000 кв. м приняли … Read more

The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang

by

NANCHANG, China, June 12, 2023 /PRNewswire/ — From 28 to 30 May 2023, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) and the 3rd China IVD Supply Chain Expo (CISCE), recognized as the world’s leading in vitro diagnostics (IVD) exhibition, were successfully closed in Nanchang, China. With an exhibition space of 130,000 sqm, the … Read more

MGI and AddLife AB Announce Strategic Collaboration for Expanded Distribution of MGI products* in the Nordic Region

by

STOCKHOLM, June 8, 2023 /PRNewswire/ — MGI Tech Co. Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, are delighted to announce a comprehensive collaboration with AddLife AB, one of Europe’s largest distributors of clinical testing and laboratory equipment, headquartered in Stockholm. This partnership aims to significantly enhance the … Read more

Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023

by

JINAN, China, June 8, 2023 /PRNewswire/ — Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023). Study One:Title: DUBHE-L-304: A randomized, double-blind, multicenter … Read more

Infiray® WIN EURASIA’da 2023’te Çıkıyor

by

YANTAI Çin, 7 Haziran 2023 /PRNewswire/ — Termal görüntüleme sektörünün önde gelen markası olan IRay Technology Co., Ltd “InfiRay®” (aşağıda “InfiRay” olarak bahsedilmektedir), “İstanbul WIN EURASIA 2023’te göze çarpan duruşuyla kendini gösterdi. InfiRay®, yenilikçi teknolojilerini tanıttı ve Türkiye İstanbul Fuar Merkezi’nde 4. hol A960 no’lu stantta termal görüntüleme ürünlerini sergiledi. InfiRay bize bir dizi kızılötesi termal … Read more

InfiRay® Debuts at WIN EURASIA 2023

by

YANTAI, China, June 7, 2023 /PRNewswire/ — IRay Technology Co., Ltd. (referred to as “InfiRay®” below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul. InfiRay® presented its innovative technologies and highlighted thermal imaging products in hall 4 booth A960 at Istanbul Expo Center, … Read more

Gavan Unveils its Plant-Based Fat Matrix to Boost Baked Goods Sensory Experience

by

Gavan introduces FaTRIXTM alternative protein-enriched fat ingredient that butters up chef pastries and slashes saturated fat by 80% ACRE, Israel, June 6, 2023 /PRNewswire/ — FoodTech start-up Gavan Technologies, Ltd. leverages its no-waste protein extraction platform to deliver FaTRIX™, a leading-edge alternative fat solution. FaTRIX offers a series of high-performance, protein-based fat substitutes that serve as … Read more

Advances of Qilu Pharmaceutical’s QL1706 in Clinical Research Presented at ASCO Annual Meeting

by

JINAN, China, May 31, 2023 /PRNewswire/ — The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four clinical research abstracts on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, were accepted in the Poster Session. Two of the posters focus on the latest clinical research progress of Qilu … Read more

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

by

OSAKA, Japan, May 29, 2023 /PRNewswire/ — RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus. Collaborators also reported that S/F-iTregs generated … Read more